New Strong Buy Stocks for December 30th

Zacks
2024-12-30

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

CoreCard Corporation CCRD: This technology solutions and processing services company has seen the Zacks Consensus Estimate for its current year earnings increasing 7% over the last 60 days.

CoreCard Corporation Price and Consensus

CoreCard Corporation price-consensus-chart | CoreCard Corporation Quote

Appian Corporation APPN: This software company has seen the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.

Appian Corporation Price and Consensus

Appian Corporation price-consensus-chart | Appian Corporation Quote

USANA Health Sciences, Inc. USNA: This nutritional, personal care, and skincare products company has seen the Zacks Consensus Estimate for its next year earnings increasing 12.8% over the last 60 days.

USANA Health Sciences, Inc. Price and Consensus

USANA Health Sciences, Inc. price-consensus-chart | USANA Health Sciences, Inc. Quote

Entrada Therapeutics, Inc. TRDA: This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 64.7% over the last 60 days.

Entrada Therapeutics, Inc. Price and Consensus

Entrada Therapeutics, Inc. price-consensus-chart | Entrada Therapeutics, Inc. Quote

NRx Pharmaceuticals, Inc. NRXP: This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 46.2% over the last 60 days.

NRx Pharmaceuticals, Inc. Price and Consensus

NRx Pharmaceuticals, Inc. price-consensus-chart | NRx Pharmaceuticals, Inc. Quote

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

USANA Health Sciences, Inc. (USNA) : Free Stock Analysis Report

Appian Corporation (APPN) : Free Stock Analysis Report

NRx Pharmaceuticals, Inc. (NRXP) : Free Stock Analysis Report

Entrada Therapeutics, Inc. (TRDA) : Free Stock Analysis Report

CoreCard Corporation (CCRD) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10